Is YS Biopharma Stock a Good Investment?

YS Biopharma Investment Advice

  YSBPW
To provide specific investment advice or recommendations on YS Biopharma Co stock, we recommend investors consider the following general factors when evaluating YS Biopharma Co. This will help you to make an informed decision on whether to include YS Biopharma in one of your diversified portfolios:
  • Examine YS Biopharma's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
  • Research YS Biopharma's leadership team and their track record. Good management can help YS Biopharma navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
  • Consider the overall health of the Stock space and any emerging trends that could impact YS Biopharma's business and its evolving consumer preferences.
  • Compare YS Biopharma's performance and market position to its competitors. Analyze how YS Biopharma is positioned in terms of product offerings, innovation, and market share.
  • Check if YS Biopharma pays a dividend and its dividend yield and payout ratio.
  • Review what financial analysts are saying about YS Biopharma's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in YS Biopharma Co stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if YS Biopharma Co is a good investment.
 
Sell
 
Buy
Strong Sell
We provide trade recommendation to complement the latest expert consensus on YS Biopharma Co. Our dynamic recommendation engine utilizes a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at this time. Please utilize YS Biopharma revenue and total asset to make buy, hold, or sell decision on YS Biopharma Co. As YS Biopharma appears to be a penny stock we also urge to confirm its number of employees numbers.

Market Performance

GoodDetails

Volatility

Out of controlDetails

Hype Condition

Over hypedDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

Quite HighDetails

Economic Sensitivity

Hyperactively responds to market trendsDetails

Investor Sentiment

ImpartialDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

UnavailableDetails

Examine YS Biopharma Stock

Researching YS Biopharma's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company had not issued any dividends in recent years.
To determine if YS Biopharma is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding YS Biopharma's research are outlined below:
YS Biopharma is way too risky over 90 days horizon
YS Biopharma has some characteristics of a very speculative penny stock
YS Biopharma appears to be risky and price may revert if volatility continues
YS Biopharma has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 687.2 M. Net Loss for the year was (283.47 M) with profit before overhead, payroll, taxes, and interest of 0.
YS Biopharma generates negative cash flow from operations

Basic technical analysis of YSBPW Stock

As of the 22nd of February, YS Biopharma owns the market risk adjusted performance of 1.31, and Standard Deviation of 31.13. Concerning fundamental indicators, the technical analysis model lets you check potential technical drivers of YS Biopharma, as well as the relationship between them. Strictly speaking, you can use this information to find out if the company will indeed mirror its model of historical prices and volume patterns, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for YS Biopharma, which can be compared to its peers in the sector. Please check out YS Biopharma market risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if YS Biopharma Co is priced fairly, providing market reflects its prevailing price of 0.054 per share. As YS Biopharma appears to be a penny stock we also urge to confirm its total risk alpha numbers.

Understand YS Biopharma's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing YS Biopharma's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

Consider YS Biopharma's intraday indicators

YS Biopharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of YS Biopharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
YS Biopharma time-series forecasting models is one of many YS Biopharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary YS Biopharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

YSBPW Stock media impact

Far too much social signal, news, headlines, and media speculation about YS Biopharma that are available to investors today. That information is available publicly through YSBPW media outlets and privately through word of mouth or via YSBPW internal channels. However, regardless of the origin, that massive amount of YSBPW data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of YS Biopharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of YS Biopharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to YS Biopharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive YS Biopharma alpha.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether YS Biopharma is a strong investment it is important to analyze YS Biopharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact YS Biopharma's future performance. For an informed investment choice regarding YSBPW Stock, refer to the following important reports:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in YS Biopharma Co. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for YSBPW Stock analysis

When running YS Biopharma's price analysis, check to measure YS Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy YS Biopharma is operating at the current time. Most of YS Biopharma's value examination focuses on studying past and present price action to predict the probability of YS Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move YS Biopharma's price. Additionally, you may evaluate how the addition of YS Biopharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
CEOs Directory
Screen CEOs from public companies around the world
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Is YS Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of YS Biopharma. If investors know YSBPW will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about YS Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of YS Biopharma is measured differently than its book value, which is the value of YSBPW that is recorded on the company's balance sheet. Investors also form their own opinion of YS Biopharma's value that differs from its market value or its book value, called intrinsic value, which is YS Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because YS Biopharma's market value can be influenced by many factors that don't directly affect YS Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between YS Biopharma's value and its price, as these two are different measures arrived at by various means. Investors typically determine if YS Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, YS Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.